IARTIntegra LifeSciences Holdings Corporation

IART Stock Price, Valuation & Chart | Integra LifeSciences Holdings Corporation

Compare

$16.810+0.19 (+1.14%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices IART intrinsic value IART calculated fair value vs price

Overview Financials Dividends Ratios

IART Historical price chart

IART Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.31B

PE Ratio7.12

EPS2.36

Trading Volume528.82K

Today's High/Low17.2/16.71

Dividend Yield0.00

52 Week High/Low20.49/8.7

Shares Outstanding77.77M

IART Financial Statement

IART Analyst ratings

IART Analysis & performance metrics

IART Company profile

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and…

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair…

IART Management team

Name

Position

Mojdeh PoulCEO

President, Chief Executive Officer & Director

Christopher WardCTO

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Robert T. Davis Jr.

Executive Vice President & President of Tissue Technologies

Jeffrey A. Mosebrook

Senior Vice President of Finance & Principal Accounting Officer

Michael J. McBreen

Executive Vice President & President of Codman Specialty Surgical

Stuart M. Essig Ph.D.

Non- Executive Chairman

Lea Daniels KnightCFO

Executive Vice President & Chief Financial Officer

Name

Position

Mojdeh PoulCEO

President, Chief Executive Officer & Director

Christopher WardCTO

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Robert T. Davis Jr.

Executive Vice President & President of Tissue Technologies

Jeffrey A. Mosebrook

Senior Vice President of Finance & Principal Accounting Officer

Michael J. McBreen

Executive Vice President & President of Codman Specialty Surgical

Stuart M. Essig Ph.D.

Non- Executive Chairman

Lea Daniels KnightCFO

Executive Vice President & Chief Financial Officer

Management Team

Mojdeh PoulCEO

President, Chief Executive Officer & Director

Christopher WardCTO

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Robert T. Davis Jr.

Executive Vice President & President of Tissue Technologies

Jeffrey A. Mosebrook

Senior Vice President of Finance & Principal Accounting Officer

Michael J. McBreen

Executive Vice President & President of Codman Specialty Surgical

Stuart M. Essig Ph.D.

Non- Executive Chairman

Lea Daniels KnightCFO

Executive Vice President & Chief Financial Officer

Management

Mojdeh PoulCEO

President, Chief Executive Officer & Director

Christopher WardCTO

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Robert T. Davis Jr.

Executive Vice President & President of Tissue Technologies

Jeffrey A. Mosebrook

Senior Vice President of Finance & Principal Accounting Officer

Michael J. McBreen

Executive Vice President & President of Codman Specialty Surgical

Stuart M. Essig Ph.D.

Non- Executive Chairman

Lea Daniels KnightCFO

Executive Vice President & Chief Financial Officer

Total 8 executives

IART Frequently asked questions

What is Integra LifeSciences Holdings Corporation (IART) Stock Price?

Current stock price of Integra LifeSciences Holdings Corporation (IART) stock is $16.810. The stock price is +1.14% higher in the session. The intraday range can be seen from this page. Volume of Integra LifeSciences Holdings Corporation (IART) stock is 528.82K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Integra LifeSciences Holdings Corporation (IART) stock price going up or down today?

The stock price of Integra LifeSciences Holdings Corporation (IART) can change with earnings, company news, and overall market sentiment. Integra LifeSciences Holdings Corporation operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Integra LifeSciences Holdings Corporation stock expensive at its current price?

Whether Integra LifeSciences Holdings Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IART on this page is 7.12. EPS on this page is 2.36. Compare those figures with peers and growth expectations before deciding if the current Integra LifeSciences Holdings Corporation price is justified.

How has the stock price of Integra LifeSciences Holdings Corporation (IART) performed historically?

Historical performance for Integra LifeSciences Holdings Corporation (IART) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IART reacted to past earnings and market events.

Should I buy Integra LifeSciences Holdings Corporation (IART) stock, at this price?

Buying Integra LifeSciences Holdings Corporation (IART) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.